Skip to main content
. Author manuscript; available in PMC: 2023 May 31.
Published in final edited form as: Surgery. 2019 May 6;166(1):15–21. doi: 10.1016/j.surg.2019.03.008

Table 3.

Association of Pathologic Factors with Risk for Lymph Node Positivity in Patients with <2 cm Low/Intermediate Grade, Non-functional, PNETs from the US-NETSG Database who underwent Curative-intent Resection from 2000–2016.

Logistic Regression
Lymph Node Positivity
Pathologic Factors OR (95% CI) p-valuea
Tumor Location in Pancreas
Distal Ref --
Proximal 4.0 (1.6–9.7) 0.002

Tumor Size
<1 cm Ref --
1–1.5 cm 1.25 (0.4–4.2) 0.716
 ≥1.5 cm 1.7 (0.5–5.9) 0.405

Tumor Differentiation
 Well Ref --
 Moderate 1.5 (0.3–6.9) 0.631

Ki-67 Index
<3% Ref --
3–20% 2.7 (1.0–7.2) 0.054

Final Resection Status
 R0 Ref --
 R1 3.3 (1.0–11.0) 0.052

Mitotic Rate (per 10 HPF)
 <2 Ref --
 2–20 3.9 (0.9–16.4) 0.062

Lymphovascular Invasion
 Negative Ref --
 Positive 17.2 (5.9–50.1) <0.001

Perineural Invasion
 Negative Ref --
 Positive 4.9 (1.7–14.0) 0.003

Advanced T Stage
 T1/T2 Ref --
 T3 8.6 (2.2–33.1) 0.002

Abbreviations: OR, odds ratio; CI, confidence interval; HPF, high power fields;

a

Statistical significance is indicated by a p<0.05.

Bold values indicate preoperatively measurable variables through imaging or biopsy.